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Abstract 26 
 27 
Phage-encoded endolysins are recently considered as new biocontrol tools to inhibit 28 
pathogens in food. In this work, we have studied the ionic requirements for optimal lytic 29 
activity of LysH5, the endolysin encoded by the staphylococcal bacteriophage phi-30 
SauS-IPLA88. LysH5 activity was inhibited by the presence of Mn++ and Zn++ and 31 
enhanced by Ca++, Mg++ and NaCl. When LysH5 was combined with nisin, a 32 
bacteriocin currently used as a biopreservative in food, a strong synergistic effect was 33 
observed. The Minimum Inhibitory Concentrations of nisin and LysH5 were reduced 34 
64- and 16-fold, respectively, as determined in checkerboard microtitre tests. In 35 
addition, nisin enhanced 8-fold the lytic activity of LysH5 on cell suspensions. The 36 
synergy observed in vitro was confirmed in challenge assays in pasteurized milk 37 
contaminated with S. aureus Sa9. Clearance of the pathogen was only achieved by the 38 
combined activity of both antimicrobials. As far as we know, this is the first study that 39 
exploits the possibilities of hurdle technology combining a phage-encoded endolysin 40 
and the bacteriocin nisin for efficient S. aureus inhibition in milk. 41 
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1. Introduction 49 
 50 
 Staphylococcus aureus is a major human pathogen that causes a wide range of 51 
diseases including food poisoning due to the production of enterotoxins (Le Loir et al., 52 
2003). Milk and dairy products are often implicated in staphylococcal outbreaks (De 53 
Buyser et al., 2001; Delbes et al., 2006). During the elaboration of dairy products, 54 
contamination by S. aureus may come from several sources including raw milk (notably 55 
milk from mastitic cows), biofilms in the processing plant environment as well as 56 
healthy human carriers. 57 
 Nisin, a bacteriocin produced by some strains of Lactococcus lactis, is used in 58 
more than 40 countries as a natural preservative in foods including dairy products 59 
(Gálvez et al., 2007). The combination of this bacteriocin with heat and non-thermal 60 
treatments, such as high pressure, pulsed electric fields and other antimicrobials has 61 
been also approached (Sobrino-López and Martín-Belloso, 2008). However, many 62 
reports have suggested that the ultimate failure of bacteriocin-based preservation 63 
systems may be due to the eventual growth of nisin-resistant strains that could 64 
compromise its use to control food-borne pathogens such as Listeria monocytogenes 65 
(Gravesen et al., 2002), Clostridium botulinum (Mazzotta et al., 1997), and S. aureus 66 
(Peschel et al., 1999).  67 
 Bacteriophage lytic enzymes have also attracted considerable interest as novel 68 
antimicrobials, mostly against gram-positive bacteria, and have been used for 69 
controlling bacterial infections and preventing pathogen colonization of mucosal 70 
membranes (Fischetti, 2008). Mixtures of endolysins with other antimicrobial agents 71 
have been previously assayed. Synergy between lysostaphin and the lysK endolysin 72 
against S. aureus has been reported (Becker et al., 2008). Similarly, the phage lytic 73 
enzyme Cpl-1 acted synergistically with gentamycin, penicillin and with the phage 74 
endolysin Pal against several penicillin-resistant and sensitive Streptococcus 75 
pneumoniae strains (Loeffler and Fischetti, 2003; Djurkovic et al., 2005). On the 76 
contrary, there are hardly any reports on the combined activity of phage endolysins with 77 
food preservatives or other preservation technologies. Very recently, it has been shown 78 
that the endolysins KZ144 and EL188 sensitize Pseudomonas aeruginosa to high 79 
hydrostatic pressure (Briers et al., 2008) 80 
 We have previously identified and characterized the endolysin LysH5 encoded 81 
by the S. aureus phage phi-SauS-IPLA88. Bioinformatic analysis of the LysH5 protein 82 
sequence revealed three putative domains, a cysteine, histidine-dependent 83 
amidohydrolase/peptidase (CHAP) domain, an amidase-2 domain, and a C-terminal 84 
SH3b cell wall-binding domain. LysH5 lysed a wide range of staphylococci including 85 
bovine and human S. aureus and Staphylococcus epidermidis and it also inhibited S. 86 
aureus growth in milk (Obeso et al., 2008). In this work, we have analysed the ionic 87 
requirements for LysH5 activity and evaluated possible synergistic effects with the 88 
bacteriocin nisin in order to explore new biopreservation strategies based on hurdle 89 
technology to effectively inhibit S. aureus in milk. 90 
 91 
2. Materials and Methods 92 
 93 
2.1. Bacterial strains and growth conditions. S. aureus Sa9 was used as the indicator 94 
strain for endolysin activity. The organism was grown in 2xYT broth (Sambrook et al., 95 
1989) at 37 °C for 18 h with vigorous shaking. E. coli BL21(DE3)/pLys containing the 96 
pRSETB-lysH5 plasmid was used to overexproduced the endolysin LysH5 (Obeso et 97 
al., 2008). 98 
 99 
2.2. LysH5 purification. Exponentially cultures (OD600 nm of 0.6-0.8) growing in 100 
shaking flasks at 37 °C were induced with 1 mM IPTG (isopropyl-beta-D-101 
thiogalactopyranoside). Three hours after induction, cells were pelleted, washed with 20 102 
mM NaH2PO4, pH 7.4 and frozen at -20 °C. For protein purification, 500 ml culture cell 103 
pellets were resuspended in 40 ml of cell resuspension buffer (iFOLD Protein Refolding 104 
System 2, Novagen, Madison, USA) and sonicated (15×5 s pulses with 15 s recovery on 105 
ice) following the manufacturer’s instructions. Inclusion bodies containing LysH5 were 106 
obtained and stored at -80 °C. They were further desnaturalized in iFold Guanidine 107 
desnaturalization buffer and folding of the protein was monitored in the iFold protein 108 
refolding matrix that includes 96 buffer conditions. The refolded protein was added to 109 
0.5 ml Ni-NTA (nickel matrix) slurry and eluted according to the manufacturer's 110 
instructions (Qiagen, Valencia, CA). Fractions containing LysH5 were dialyzed against 111 
20 mM NaH2PO4 buffer, pH 7.0, diluted in glycerol (50% final concentration), and 112 
stored at -80 °C. Purity of each preparation was determined in 15% (w/v) SDS-PAGE 113 
gels. Electrophoresis was conducted in Tris-Glycine buffer at 20 mA for 1 h in the 114 
BioRad Mini-Protean gel apparatus. Protein was quantified by the Quick Start Bradford 115 
Protein Assay (BioRad, Hercules, CA). 116 
 117 
2.3. Turbidity reduction assays. The turbidity assay was performed in a Microplate 118 
Spectrophotometer Benchmark Plus (BioRad, Hercules, CA) as previously described 119 
(Obeso et al., 2008). The enzymatic activity of LysH5 was determined in salt buffers 120 
composed of 50 mM phosphate buffer, pH 7.0 with NaCl ranging from 0 to 500 mM. 121 
Activity was also assayed in the presence of several cations (CaCl2, MgCl2, MnCl2 and 122 
ZnCl2) at concentrations ranging from 0 to 1 mM. 123 
 124 
2.4. Checkerboard microtiter tests. Susceptibilities to nisin and the endolysin, and the 125 
putative synergism between both antimicrobials, were determined by microdilution in 126 
microtiter plates as previously described (Martínez et al., 2008). Minimum inhibitory 127 
concentrations (MICs) of nisin and endolysin were defined as the lowest concentration 128 
at which growth of the indicator organism was totally inhibited after 18 h incubation at 129 
37 °C. To calculate MICs, two-fold serial dilutions of nisin from 3 µg/ml to 0.002 µg/ml 130 
and endolysin from 50 U/ml to 0.78 U/ml were used. To determine the synergistic effect 131 
between nisin and endolysin a checkerboard test (White et al., 1996) was carried out. 132 
Wells containing nisin (0.75 µg/ml to 0.00075 µg/ml) were combined with LysH5 (50 133 
U/ml to 0.78 U/ml). In this test, up to 45 different combinations of nisin and the 134 
endolysin were tested. Controls with each nisin or endolysin concentration were also 135 
included separately. The fractional inhibitory concentration (FIC) was calculated as the 136 
MIC of the antimicrobial in combination divided by the MIC of the antimicrobial acting 137 
alone. Strong synergy exists if the sum of the two FICs [∑FIC = FICA+ FICB] is <0.5 138 
(Hall et al., 1983). All the experiments were performed in duplicate.  139 
A similar checkerboard test was performed with S. aureus Sa9 suspensions in 50 mM 140 
phosphate buffer, pH 7.0, to a final OD 600 nm of 1.5 as described in section 2.3. 141 
Minimum lysis concentrations (MLCs) of nisin and endolysin individually and in 142 
combination were determined. MLCs were defined as the lowest concentration at which 143 
total cell lysis was obtained after 15 min of incubation at 37 °C. The fractional 144 
inhibitory concentration (FIC) was calculated as described above. In this case, wells 145 
containing nisin (6 µg/ml to 0.005 µg/ml) were combined with endolysin (5 U/ml to 146 
0.078 U/ml).  147 
 148 
2.5. Challenge tests in pasteurized milk. Commercial pasteurized milk was inoculated 149 
with 102 cfu/ml and 105 cfu/ml of S. aureus Sa9. Immediately after, nisin (0.37 µg/ml 150 
and 0.75 µg/ml), endolysin (7.5 U/ml and 15 U/ml) and a mixture of both, were also 151 
added. The milk was incubated at 37 °C without shaking and samples were taken at 152 
various times. Survival of S. aureus was determined by plating decimal dilutions on 153 
plates of Baird–Parker selective agar (Scharlab, Barcelona, Spain) which were 154 
incubated at 37 °C for 24 h. 155 
 156 
3. Results and Discussion.  157 
 158 
3.1. Improved purification and lytic activity of the endolysin LysH5. Previous 159 
attempts to purify the endolysin LysH5 after overexpression of E. coli BL21(DE3)/pLys 160 
cultures containing pRSETB-lysH5 (Obeso et al., 2008) gave low yields owing to the 161 
poor solubility of the protein. Therefore, we proceeded to improve the recovery of 162 
LysH5 from inclusion bodies and subsequent refolding. Using the iFOLD Protein 163 
Refolding System 2, the highest solubility was obtained by refolding in buffer A: CHES 164 
50 mM, PEG 3350 0.06%, CaCl2 0.25 mM, MnCl2 0.25 mM, ZnCl2 0.25 mM, TCEP 1 165 
mM, pH 9. In this way, the purification yield was 128 Units per ml of induced E. coli 166 
culture, which means an increase of 35 times compared to our previous reports (Obeso 167 
et al., 2008).  168 
 To assess the optimal conditions for LysH5 activity, turbidity reduction assays 169 
with S. aureus Sa9 cells were carried out using 4 µg of LysH5 (10 U/ml, final 170 
concentration). Several concentrations of NaCl and the presence of other cations (CaCl2, 171 
MgCl2, MnCl2 and ZnCl2) were tested (Fig. 1). LysH5 activity was clearly inhibited by 172 
the presence of ZnCl2 and MnCl2, even at low concentrations (Fig. 1A). On the contrary, 173 
MgCl2 and CaCl2 clearly enhanced activity of LysH5. A similar requirement of Ca2+ (2-174 
3 mM) was described for the S. aureus bacteriophage phi11 endolysin (Donovan et al., 175 
2006). It has also been suggested that divalent cations may be associated with the pure 176 
enzymes and be required for activity and/or structural stability of peptidoglycan 177 
hydrolases (Llull et al., 2006). These Ca2+ values are in accordance with the calcium 178 
content in milk and, thereby, may promote the lytic activity of these proteins in this 179 
food matrix. The endolysin LysH5 showed higher activity in the presence of any NaCl 180 
concentration tested with maximal activity at concentrations close to 100 mM (Fig. 1B). 181 
According to these results, the optimal buffer conditions for the turbidity reduction 182 
assays were defined as: phosphate buffer 50 mM, CaCl2 1 mM, MgCl2 1 mM, NaCl 100 183 
mM, pH 7.0. 184 
 185 
3.2. In vitro synergy between nisin and LysH5. Initially, minimum inhibitory 186 
concentrations (MICs) of nisin and the endolysin were determined by using 187 
exponentially growing cultures of S. aureus Sa9. The MICs of nisin and LysH5 were 3 188 
µg/ml and 50 U/ml, respectively (data not shown). When both nisin and the endolysin 189 
were combined in the checkerboard microtiter test, a synergistic effect was observed. In 190 
the presence of subinhibitory concentrations of nisin, a lower endolysin concentration 191 
was needed to fully inhibit S. aureus Sa9 growth (Fig. 2A). Thus, growth inhibition by 192 
the two antimicrobials in combination was greater than either alone. From the 193 
checkerboard test, it could be concluded that the most effective conditions to inhibit 194 
bacterial growth were 0.75 µg/ml and 3.1 U/ml, or 0.045 µg/ml and 12.5 U/ml for nisin 195 
and LysH5, respectively. These values implied up to a 64-fold and 16-fold reduction of 196 
the nisin and endolysin MICs, respectively, when used in combination. The average 197 
∑FIC was 0.155±0.06 (n=3) highlighting the strong synergy between both 198 
antimicrobials.  199 
 Many approaches to enhancing the antagonistic activity of nisin and expand its 200 
range of application have been tried. Nisin has been found to act synergistically with 201 
various antimicrobials including chelators (Fang and Tsai, 2003), small molecular 202 
weight substances from plants (Ettayebi et al., 2000), reuterin (Arqués et al., 2004), 203 
proteins such as lysozyme and lactoferrin (Branen and Davidson, 2004) and milk-204 
derived peptides (López-Expósito et al., 2008). The positive interaction between the 205 
endolysin LysH5 and nisin could be due to a better access to their respective cleavage 206 
and binding site promoted by the other compound, or based on an enhanced 207 
peptidoglycan hydrolase activity through the dissipation of the membrane proton motive 208 
force by nisin. It has been shown that nisin triggered activity of the endolysin Lys44 by 209 
mimicking the holin disruption of the cytoplasmic membrane electrical and chemical 210 
gradients (Nascimiento et al., 2008). 211 
 To get a deeper insight into the synergy between nisin and LysH5, a 212 
checkerboard test was performed using metabolic arrested cells in buffer. These are the 213 
conditions which are routinely assayed to measure peptidoglycan hydrolytic activities. 214 
Under these conditions, the minimum lysis concentration (MLC) of LysH5 was 2.5 215 
U/ml while nisin (more than 6 µg/ml) did not lyse the cells (data not shown). In this 216 
assay, the effective LysH5 concentration was lower than that needed to inhibit S. aureus 217 
growth in the MIC assay, showing than cell suspensions are more sensitive to the 218 
endolysin action than exponentially growing cells. It is possible to speculate that the 219 
higher sensitivity of S. aureus cell suspensions might be due to a lower peptidoglycan 220 
turnover in these metabolic arrested cells which would be unable to counteract the 221 
peptidoglycan breaks generated by LysH5. Nevertheless, the endolysin MLC against S. 222 
aureus suspensions could be even reduced in the presence of nisin (Fig. 2B). The most 223 
effective conditions to properly lyse S. aureus Sa9 bacterial suspensions identified in 224 
this assay were 1.5 µg/ml and 0.3 U/ml or 0.180 µg/ml and 1.25 U/ml of nisin and 225 
endolysin, respectively. The ∑FIC for S. aureus suspensions was 0.077± 0.01 indicating 226 
again a strong synergistic activity where, the presence of nisin enhanced LysH5 activity 227 
up to 8-fold. These results further support that LysH5 activity might be increased by the 228 
permeabilization of the cytoplasmic membrane by nisin as described for the endolysin 229 
Lys44 (Nascimiento et al., 2008). Also, partial activation of autolysins by nisin may 230 
occur and facilitate LysH5 activity (Bierbaum and Sahl, 1985). Nonetheless, the basis of 231 
the synergy between nisin and LysH5 deserves further investigation.  232 
 233 
3.3. Enhanced inhibition of S. aureus growth in milk. In view of the synergy between 234 
nisin and LysH5 in vitro, we proceeded to verify if a combination of both antimicrobials 235 
would be more effective to inhibit S. aureus growth in milk. Challenge assays in 236 
pasteurized milk were carried out using two levels of S. aureus Sa9 contamination (102 237 
cfu/ml and 105 cfu/ml). Nisin (0.37 µg/ml and 0.75 µg/ml), endolysin LysH5 (7.5 U/ml 238 
and 15 U/ml) and a mixture of both were tested. The addition of LysH5 had only a 239 
slight inhibitory effect on S. aureus growth regardless the contamination level (Fig. 3). 240 
On the contrary, the addition of nisin inhibited S. aureus multiplication in milk and kept 241 
the initial cell counts constant (Fig. 3). However, a complete clearance of the pathogen 242 
was only obtained in the presence of the mixture (LysH5 and nisin) after 6 h of 243 
incubation. The inhibitory effect of both antimicrobials was already noticeable after 4 h 244 
and the counts were 4 and 6 unit-log below the control culture at both low (Fig. 3A) and 245 
higher (Fig. 3B) contamination levels, respectively. 246 
As anticipated by the in vitro results, the mixture was also more efficient in a food 247 
matrix than each antimicrobial alone. A similar synergistic effect between nisin and 248 
bacteriophages against S. aureus in milk was previously described in short-time 249 
challenge tests (Martínez et al., 2008). However, bacteriophage cross-resistance arose in 250 
nisin-adapted mutants. This seems not to be the case with the endolysin LysH5 as these 251 
nisin mutants were still sensitive to LysH5 (data not shown). Another advantage over 252 
bacteriophages is that the combination of LysH5 and nisin was also successful at low 253 
pathogen concentration, opposite to the bacteriophages that require a minimum host 254 
threshold to be effective (Cairns et al., 2009). In conclusion, our results support the use 255 
of phage endolysins as non-traditional food preservatives in combination with the 256 
commonly used preservative nisin to inhibit pathogens in food matrices more 257 
efficiently. Further studies to determine endolysin stability under food processing 258 
conditions, as well as oral toxicity studies are in progress. 259 
 260 
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6. Figures 378 
 379 
 380 
Figure 1. Optimization of turbidity reduction assay conditions for His-tagged LysH5 in 381 
the presence of several cations (A) and NaCl (B). (A) Cations were added to the 382 
reaction at 0.25 mM (light grey bars), 0.5 mM (dark grey bars), 0.75 mM (black bars), 383 
and 1 mM (striped bars). The lytic activity in phosphate buffer 50 mM, pH 7.0 without 384 
cations and NaCl was taken as 100% (white bars). Error bars represent standard 385 
deviation of three independent measurements.  386 
 387 
Figure 2. Minimum Inhibitory Concentration (MIC) and Minimum Lysis Concentration 388 
(MLC) of the endolysin LysH5 in the presence of subinhibitory concentrations of nisin. 389 
A) S. aureus Sa9 culture. The MIC of nisin for S. aureus Sa9 was 3 µg/ml in these assay 390 
conditions. B) Turbidity reduction assay. The MLC of nisin for S. aureus Sa9 was > 6 391 
µg/ml in these assay conditions. 392 
 393 
Figure 3. Killing of S. aureus Sa9 with purified LysH5 and nisin in pasteurized whole 394 
milk. A) ♦, cell numbers of S. aureus Sa9; ■, LysH5 (7.5 U/ml); □, nisin (0.37 µg/ml); 395 
▲, LysH5 (7.5 U/ml) and nisin (0.37 µg/ml). B) ♦, cell numbers of S. aureus Sa9; ■, 396 
LysH5 (15 U/ml); □, nisin (0.75 µg/ml); ▲, LysH5 (15 U/ml) and nisin (0.75 µg/ml). 397 
Values are the means of two independent experiments with standard deviation indicated 398 
by vertical bars. 399 
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